Home > M&A deals 2016 > First Analysis Corp. invests in Apixio, Inc.
Venture · Medical Products · May 2016

First Analysis Corp. invests in Apixio, Inc.

On May 24, 2016, First Analysis Corp. invested in Apixio, Inc., a medical products company in California, United States.

Deal at a glance

AnnouncedMay 24, 2016 TypeVenture TargetApixio, Inc. Buyer First Analysis Corp. SectorMedical Products LocationCalifornia, United States ValueNot disclosed

Target company

Apixio, Inc.
California, United States
Medical Productssector
2004founded
Activestatus
View the company profile →

Buyer

First Analysis Corp.
Private equity firm · 111 deals on record
  • 8th transaction in medical products
  • 41st transaction in United States
111deals, all time
8in this sector
2020latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Seraplex, Inc.Same sector and country · Oct 2026
Aloe Care Health, Inc.Same sector and country · Apr 2026
Hologic, Inc.Same sector and country · Apr 2026

Questions about this deal

Who acquired Apixio, Inc.?First Analysis Corp. invested in Apixio, Inc. on May 24, 2016.

What type of deal was it?It was a venture in the medical products sector in 2016.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).